Literature DB >> 21050542

A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients.

H G Kim1, D P Tashkin, P J Clements, G Li, M S Brown, R Elashoff, D W Gjertson, F Abtin, D A Lynch, D C Strollo, J G Goldin.   

Abstract

OBJECTIVES: To evaluate an improved quantitative lung fibrosis score based on a computer-aided diagnosis (CAD) system that classifies CT pixels with the visual semi-quantitative pulmonary fibrosis score in patients with scleroderma-related interstitial lung disease (SSc-ILD).
METHODS: High-resolution, thin-section CT images were obtained and analysed on 129 subjects with SSc-ILD (36 men, 93 women; mean age 48.8±12.1 years) who underwent baseline CT in the prone position at full inspiration. The CAD system segmented each lung of each patient into 3 zones. A quantitative lung fibrosis (QLF) score was established via 5 steps: 1) images were denoised; 2) images were grid sampled; 3) the characteristics of grid intensities were converted into texture features; 4) texture features classified pixels as fibrotic or non-fibrotic, with fibrosis defined by a reticular pattern with architectural distortion; and 5) fibrotic pixels were reported as percentages. Quantitative scores were obtained from 709 zones with complete data and then compared with ordinal scores from two independent expert radiologists. ROC curve analyses were used to measure performance.
RESULTS: When the two radiologists agreed that fibrosis affected more than 1% or 25% of a zone or zones, the areas under the ROC curves for QLF score were 0.86 and 0.96, respectively.
CONCLUSIONS: Our technique exhibited good accuracy for detecting fibrosis at a threshold of both 1% (i.e. presence or absence of pulmonary fibrosis) and a clinically meaningful threshold of 25% extent of fibrosis in patients with SSc-ILD.

Entities:  

Mesh:

Year:  2010        PMID: 21050542      PMCID: PMC3177564     

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  27 in total

1.  Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life.

Authors:  Gianna Camiciottoli; Ilaria Orlandi; Maurizio Bartolucci; Eleonora Meoni; Francesca Nacci; Stefano Diciotti; Chiara Barcaroli; Maria Letizia Conforti; Massimo Pistolesi; Marco Matucci-Cerinic; Mario Mascalchi
Journal:  Chest       Date:  2007-03       Impact factor: 9.410

2.  Scleroderma lung disease: "if you don't know where you are going, any road will take you there".

Authors:  Charlie Strange; James R Seibold
Journal:  Am J Respir Crit Care Med       Date:  2008-06-01       Impact factor: 21.405

3.  Comparison of computed density and macroscopic morphometry in pulmonary emphysema.

Authors:  P A Gevenois; V de Maertelaer; P De Vuyst; J Zanen; J C Yernault
Journal:  Am J Respir Crit Care Med       Date:  1995-08       Impact factor: 21.405

4.  Computer recognition of regional lung disease patterns.

Authors:  R Uppaluri; E A Hoffman; M Sonka; P G Hartley; G W Hunninghake; G McLennan
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

5.  Automated measurement of single and total lung volume from CT.

Authors:  M S Brown; M F McNitt-Gray; J G Goldin; L E Greaser; U M Hayward; J W Sayre; M K Arid; D R Aberle
Journal:  J Comput Assist Tomogr       Date:  1999 Jul-Aug       Impact factor: 1.826

6.  [Quantitative assessment of pulmonary emphysema with computerized tomography. Comparison of the visual score and high resolution computerized tomography, expiratory density mask with spiral computerized tomography and respiratory function tests].

Authors:  M Zompatori; M Battaglia; M R Rimondi; L Fasano; M Cavina; A M Pacilli; A Guerrieri; M Fabbri; D Vivacqua; M Biscarini
Journal:  Radiol Med       Date:  1997-04       Impact factor: 3.469

7.  Obstructive lung diseases: texture classification for differentiation at CT.

Authors:  Francois Chabat; Guang-Zhong Yang; David M Hansell
Journal:  Radiology       Date:  2003-07-17       Impact factor: 11.105

8.  Classification of parenchymal abnormality in scleroderma lung using a novel approach to denoise images collected via a multicenter study.

Authors:  Hyun J Kim; Gang Li; David Gjertson; Robert Elashoff; Sumit K Shah; Robert Ochs; Fah Vasunilashorn; Fereidoun Abtin; Matthew S Brown; Jonathan G Goldin
Journal:  Acad Radiol       Date:  2008-08       Impact factor: 3.173

9.  Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality.

Authors:  Alan C Best; Jiangfeng Meng; Anne M Lynch; Carmen M Bozic; David Miller; Gary K Grunwald; David A Lynch
Journal:  Radiology       Date:  2008-01-30       Impact factor: 11.105

10.  "Density mask". An objective method to quantitate emphysema using computed tomography.

Authors:  N L Müller; C A Staples; R R Miller; R T Abboud
Journal:  Chest       Date:  1988-10       Impact factor: 9.410

View more
  55 in total

Review 1.  Quantitative pulmonary imaging using computed tomography and magnetic resonance imaging.

Authors:  George R Washko; Grace Parraga; Harvey O Coxson
Journal:  Respirology       Date:  2012-04       Impact factor: 6.424

2.  Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18.

Authors:  Elizabeth R Volkmann; Donald P Tashkin; Masataka Kuwana; Ning Li; Michael D Roth; Julio Charles; Faye N Hant; Galina S Bogatkevich; Tanjina Akter; Grace Kim; Jonathan Goldin; Dinesh Khanna; Philip J Clements; Daniel E Furst; Robert M Elashoff; Richard M Silver; Shervin Assassi
Journal:  Arthritis Rheumatol       Date:  2019-11-01       Impact factor: 10.995

3.  Utility of an open-source DICOM viewer software (OsiriX) to assess pulmonary fibrosis in systemic sclerosis: preliminary results.

Authors:  Alarico Ariani; Marina Carotti; Marwin Gutierrez; Elisabetta Bichisecchi; Walter Grassi; Gian Marco Giuseppetti; Fausto Salaffi
Journal:  Rheumatol Int       Date:  2013-08-15       Impact factor: 2.631

4.  Automated 3D ιnterstitial lung disease εxtent quantification: performance evaluation and correlation to PFTs.

Authors:  Alexandra Kazantzi; Lena Costaridou; Spyros Skiadopoulos; Panayiotis Korfiatis; Anna Karahaliou; Dimitris Daoussis; Andreas Andonopoulos; Christina Kalogeropoulou
Journal:  J Digit Imaging       Date:  2014-06       Impact factor: 4.056

5.  Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II.

Authors:  Jonathan G Goldin; Grace Hyun J Kim; Chi-Hong Tseng; Elizabeth Volkmann; Daniel Furst; Philip Clements; Matt Brown; Michael Roth; Dinesh Khanna; Donald P Tashkin
Journal:  Ann Am Thorac Soc       Date:  2018-11

6.  Correlation of delta high-resolution computed tomography (HRCT) score with delta clinical variables in early systemic sclerosis (SSc) patients.

Authors:  Suparaporn Wangkaew; Juntima Euathrongchit; Pittaporn Wattanawittawas; Nuntana Kasitanon
Journal:  Quant Imaging Med Surg       Date:  2016-08

7.  Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide.

Authors:  Hyun J Kim; Matthew S Brown; Robert Elashoff; Gang Li; David W Gjertson; David A Lynch; Diane C Strollo; Eric Kleerup; Daniel Chong; Sumit K Shah; Shama Ahmad; Fereidoun Abtin; Donald P Tashkin; Jonathan G Goldin
Journal:  Eur Radiol       Date:  2011-09-17       Impact factor: 5.315

8.  The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis.

Authors:  Elizabeth R Volkmann; Donald P Tashkin; Michael D Roth; Ning Li; Julio Charles; Maureen Mayes; Grace Kim; Jonathan Goldin; Lila Pourzand; Philip J Clements; Daniel E Furst; Dinesh Khanna; Robert M Elashoff; Shervin Assassi
Journal:  Semin Arthritis Rheum       Date:  2020-06-16       Impact factor: 5.532

9.  Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II.

Authors:  Donald P Tashkin; Elizabeth R Volkmann; Chi-Hong Tseng; Michael D Roth; Dinesh Khanna; Daniel E Furst; Philip J Clements; Arthur Theodore; Suzanne Kafaja; Grace Hyun Kim; Jonathan Goldin; Edgar Ariolla; Robert M Elashoff
Journal:  Chest       Date:  2016-12-22       Impact factor: 9.410

10.  Development of a Composite Outcome Measure for Systemic Sclerosis Related Interstitial Lung Disease.

Authors:  Elizabeth R Volkmann; Donald P Tashkin; Ning Li; Daniel E Furst; Philip J Clements; Robert M Elashoff
Journal:  Rheumatology (Sunnyvale)       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.